These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37309615)
1. Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancer. Mahen KK; Markley L; Bogart J; Klatka H; Krishna V; Maytin EV; Stark GR; McDonald C Exp Dermatol; 2023 Sep; 32(9):1485-1497. PubMed ID: 37309615 [TBL] [Abstract][Full Text] [Related]
2. Topical Immunotherapy for Actinic Keratosis and Field Cancerization. Bernal Masferrer L; Gracia Cazaña T; Bernad Alonso I; Álvarez-Salafranca M; Almenara Blasco M; Gallego Rentero M; Juarranz de la Fuente Á; Gilaberte Y Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539468 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies. Gupta AK; Davey V; Mcphail H J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198 [TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Tillman DK; Carroll MT Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590 [TBL] [Abstract][Full Text] [Related]
11. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. Philipp-Dormston WG Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215 [TBL] [Abstract][Full Text] [Related]
12. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer. van Ruth S; Jansman FG; Sanders CJ Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017 [TBL] [Abstract][Full Text] [Related]
13. Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer. Lucena SR; Salazar N; Gracia-Cazaña T; Zamarrón A; González S; Juarranz Á; Gilaberte Y Int J Mol Sci; 2015 Oct; 16(10):25912-33. PubMed ID: 26516853 [TBL] [Abstract][Full Text] [Related]
14. A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers. Nahm WJ; Shen J; Zito PM; Gonzalez AM; Nagrani N; Moore K; Badiavas EV; Kirsner RS; Nichols AJ J Drugs Dermatol; 2021 Mar; 20(3):260-267. PubMed ID: 33683072 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase. Johnson RK; Inouye T; Goldin A; Stark GR Cancer Res; 1976 Aug; 36(8):2720-5. PubMed ID: 1064466 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208 [TBL] [Abstract][Full Text] [Related]
18. A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies. Sinclair R; Baker C; Spelman L; Supranowicz M; MacMahon B Australas J Dermatol; 2021 May; 62(2):119-123. PubMed ID: 32840870 [TBL] [Abstract][Full Text] [Related]
19. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy. Cunningham TJ; Tabacchi M; Eliane JP; Tuchayi SM; Manivasagam S; Mirzaalian H; Turkoz A; Kopan R; Schaffer A; Saavedra AP; Wallendorf M; Cornelius LA; Demehri S J Clin Invest; 2017 Jan; 127(1):106-116. PubMed ID: 27869649 [TBL] [Abstract][Full Text] [Related]
20. Topical therapy for actinic keratoses: current and evolving therapies. Weinberg JM Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]